Similarly, in patients with clear cell renal cell carcinoma (ccRCC), higher IFIT2 expression correlated with improved overall survival, compared to patients with lower IFIT2 expression [56]. The gene discussed is IFIT2; the disease is clear cell renal carcinoma.